Home>
US Stocks>
Amphastar Pharmaceuticals

Amphastar Pharmaceuticals share price today

(AMPH)

Amphastar Pharmaceuticals share price is $39.14 & ₹3,325.96 as on 21 Dec 2024, 2.30 'hrs' IST

$39.14

▲

-0.25

(-0.63%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Amphastar Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Amphastar Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Amphastar Pharmaceuticals. Get details on the Indian mutual funds that are investing in Amphastar Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Amphastar Pharmaceuticals's financials.

Amphastar Pharmaceuticals share price movements

Today's Low: $39.06
Today's High: $40.70
$39.14
0.2%
Downside
Day's Volatility :4.02%
Upside
3.82%
52 Weeks Low: $36.56
52 Weeks High: $65.92
$39.14
6.59%
Downside
52 Weeks Volatility :44.54%
Upside
40.63%

Amphastar Pharmaceuticals Returns

Period	Amphastar Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.97%	-12.2%	0.0%
6 Months	-3.55%	-6.9%	0.0%
1 Year	-35.34%	2.7%	0.0%
3 Years	73.45%	-0.2%	-17.3%

Amphastar Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$39.39
Open	$39.31
Today's High	$40.695
Today's Low	$39.06
Market Capitalization	$1.9B
Today's Volume	$666.2K
52 Week High	$65.9249
52 Week Low	$36.56
Revenue TTM	$723.5M
EBITDA	$266.6M
Earnings Per Share (EPS)	$3.01
PE Ratio	13.11
Profit Margin	21.8%
Quarterly Earnings Growth YOY	-0.14%
Return On Equity TTM	23.85%

How to invest in Amphastar Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Amphastar Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amphastar Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amphastar Pharmaceuticals or AMPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amphastar Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amphastar Pharmaceuticals shares which would translate to 0.022 fractional shares of Amphastar Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Amphastar Pharmaceuticals, in just a few clicks!

Returns in Amphastar Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Amphastar Pharmaceuticals investment value today

Current value as on today

₹1,37,847

Returns

₹37,847

(+37.85%)

Returns from Amphastar Pharmaceuticals Stock

₹35,752 (false-35.75%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Amphastar Pharmaceuticals

-27%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Amphastar Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -27% less investors are searching Amphastar Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Amphastar Pharmaceuticals

BlackRock Inc
12.36%
Vanguard Group Inc
5.64%
TD Asset Management Inc
4.44%
Federated Hermes Inc
4.05%
Neuberger Berman Group LLC
3.36%
State Street Corp
3.18%

Analyst Recommendation on Amphastar Pharmaceuticals

Buy

75%Buy

25%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Amphastar Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Amphastar Pharmaceuticals

What analysts predicted

Upside of 48.7%

Current:

$39.14

Target:

$58.20

Insights on Amphastar Pharmaceuticals

Price Movement
In the last 3 years, AMPH stock has moved up by 77.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 171.83M → 188.81M (in $), with an average increase of 4.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 37.94M → 40.42M (in $), with an average increase of 6.1% per quarter
AMPH vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 19.9% return, outperforming this stock by 52.6%
Price to Sales
ForAMPH every $1 of sales, investors are willing to pay $2.6, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Amphastar Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$294.7M	↑ 22.69%
Net Income	$-5.7M	↓ 227.28%
Net Profit Margin	-1.95%	↓ 3.83%

	FY19	Y/Y Change
Revenue	$322.4M	↑ 9.4%
Net Income	$48.9M	↓ 952.89%
Net Profit Margin	15.18%	↑ 17.13%

	FY20	Y/Y Change
Revenue	$349.8M	↑ 8.53%
Net Income	$1.1M	↓ 97.76%
Net Profit Margin	0.31%	↓ 14.87%

	FY21	Y/Y Change
Revenue	$437.8M	↑ 25.13%
Net Income	$62.1M	↑ 5562.35%
Net Profit Margin	14.19%	↑ 13.88%

	FY22	Y/Y Change
Revenue	$499.0M	↑ 13.98%
Net Income	$91.4M	↑ 47.12%
Net Profit Margin	18.31%	↑ 4.12%

	FY23	Y/Y Change
Revenue	$644.4M	↑ 29.14%
Net Income	$137.5M	↑ 50.51%
Net Profit Margin	21.34%	↑ 3.03%

	Q2 FY23	Q/Q Change
Revenue	$145.7M	↑ 4.06%
Net Income	$26.1M	↑ 0.35%
Net Profit Margin	17.93%	↓ 0.66%

	Q3 FY23	Q/Q Change
Revenue	$180.6M	↑ 23.91%
Net Income	$49.2M	↑ 88.42%
Net Profit Margin	27.26%	↑ 9.33%

	Q4 FY23	Q/Q Change
Revenue	$178.1M	↓ 1.36%
Net Income	$36.2M	↓ 26.52%
Net Profit Margin	20.31%	↓ 6.95%

	Q1 FY24	Q/Q Change
Revenue	$171.8M	↓ 3.52%
Net Income	$43.2M	↑ 19.38%
Net Profit Margin	25.13%	↑ 4.82%

	Q2 FY24	Q/Q Change
Revenue	$182.4M	↑ 6.14%
Net Income	$37.9M	↓ 12.11%
Net Profit Margin	20.81%	↓ 4.32%

	Q3 FY24	Q/Q Change
Revenue	$188.8M	↑ 3.52%
Net Income	$40.4M	↑ 6.54%
Net Profit Margin	21.41%	↑ 0.6%

	FY18	Y/Y Change
Profit	$107.0M	↑ 17.83%

	FY19	Y/Y Change
Profit	$131.9M	↑ 23.31%

	FY20	Y/Y Change
Profit	$143.3M	↑ 8.65%

	FY21	Y/Y Change
Profit	$199.7M	↑ 39.35%

	FY22	Y/Y Change
Profit	$248.9M	↑ 24.59%

	FY23	Y/Y Change
Profit	$351.1M	↑ 41.09%

	Q2 FY23	Q/Q Change
Profit	$72.7M	↓ 1.49%

	Q3 FY23	Q/Q Change
Profit	$108.4M	↑ 49.03%

	Q4 FY23	Q/Q Change
Profit	$93.6M	↓ 13.69%

	Q1 FY24	Q/Q Change
Profit	$87.3M	↓ 6.71%

	Q2 FY24	Q/Q Change
Profit	$92.0M	↑ 5.45%

	Q3 FY24	Q/Q Change
Profit	$101.9M	↑ 10.75%

	FY18	Y/Y Change
Operating Cash Flow	$38.2M	↓ 2.6%
Investing Cash Flow	$-42.2M	↑ 8.84%
Financing Cash Flow	$25.0M	↓ 424.02%

	FY19	Y/Y Change
Operating Cash Flow	$41.8M	↑ 9.35%
Investing Cash Flow	$-50.5M	↑ 19.78%
Financing Cash Flow	$-3.8M	↓ 115.13%

	FY20	Y/Y Change
Operating Cash Flow	$57.3M	↑ 37.12%
Investing Cash Flow	$-36.4M	↓ 27.93%
Financing Cash Flow	$-2.2M	↓ 40.63%

	FY21	Y/Y Change
Operating Cash Flow	$98.0M	↑ 71.12%
Investing Cash Flow	$-28.7M	↓ 21.26%
Financing Cash Flow	$-37.0M	↑ 1548.17%

	FY22	Y/Y Change
Operating Cash Flow	$89.2M	↓ 8.99%
Investing Cash Flow	$-32.8M	↑ 14.32%
Financing Cash Flow	$-26.4M	↓ 28.58%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$54.9M	↑ 36.01%
Investing Cash Flow	$-508.6M	↑ 7930.66%
Financing Cash Flow	$428.1M	↓ 3259.96%

Amphastar Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amphastar Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Amphastar Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amphastar Pharmaceuticals Inc	-10.66%	-3.55%	-35.34%	73.45%	102.52%
Neurocrine Biosciences Inc.	9.47%	1.0%	5.07%	58.94%	24.49%
Haleon Plc Spon Ads	2.32%	12.27%	19.02%	30.9%	30.9%
Zoetis Inc.	-6.92%	-4.84%	-16.13%	-32.31%	23.53%
Viatris Inc.	-7.62%	15.85%	13.9%	-8.45%	-25.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amphastar Pharmaceuticals Inc	13.11	13.11	2.77	3.89	0.24	0.09	NA	15.04
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.56	28.56	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	31.33	31.33	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amphastar Pharmaceuticals Inc	Buy	$1.9B	102.52%	13.11	21.8%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.49%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.2B	30.9%	28.56	10.75%
Zoetis Inc.	Buy	$75.3B	23.53%	31.33	26.55%
Viatris Inc.	Hold	$14.6B	-25.76%	224.4	-5.87%

About Amphastar Pharmaceuticals

amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int

Organization	Amphastar Pharmaceuticals
Employees	1761
CEO	Dr. Ziping Luo Ph.D.
Industry	Health Technology

Management People of Amphastar Pharmaceuticals

Name	Title
Dr. Ziping Luo Ph.D.	Chairman of the Board, Chief Scientist & COO
Dr. Yongfeng Zhang Ph.D.	Co-Founder, President, CEO, Chief Scientific Officer & Director
Mr. William J. Peters M.B.A.	CFO, Executive VP of Finance, Treasurer & Director
Mr. Jacob Liawatidewi M.B.A.	Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director
Mr. Rong Zhou M.S.	Senior EVP of Production & EVP of Scientific Affairs
Mr. Dan Dischner M.B.A.	Senior Vice President of Human Resources & Corporate Communication
Tony Marrs M.B.A., M.P.H., M.S.	Executive VP of Regulatory Affairs & Clinical Operations

Important FAQs about investing in Amphastar Pharmaceuticals from India :

What is Amphastar Pharmaceuticals share price today?

Amphastar Pharmaceuticals share price today stands at $39.14, Open: $39.31 ; Previous Close: $39.39 ; High: $40.70 ; Low: $39.06 ; 52 Week High: $65.92 ; 52 Week Low: $36.56. The stock opens at $39.31, after a previous close of $39.39. The stock reached a daily high of $40.70 and a low of $39.06, with a 52-week high of $65.92 and a 52-week low of $36.56.

Can Indians buy Amphastar Pharmaceuticals shares?

Yes, Indians can invest in the Amphastar Pharmaceuticals (AMPH) from India.

With INDmoney, you can buy Amphastar Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Amphastar Pharmaceuticals at zero transaction cost.

How can I buy Amphastar Pharmaceuticals shares from India?

It is very easy to buy Amphastar Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amphastar Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Amphastar Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Amphastar Pharmaceuticals stocks?

To start investing in Amphastar Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.